Franz Wagner
ORL
Has been available for roughly 70% of games across recent seasons, which pulls the games projection down.
Value
+4.54
League Leader33.5
This Player20.6
League Average11.0
Ranking Trend
Lower rank is better.
Full data
| Season | Rank |
|---|---|
| 21-22 | #94 |
| 22-23 | #100 |
| 23-24 | #58 |
| 24-25 | #32 |
| 25-26 | #81 |
| 26-27 Projection | #59 |
Stat Trend
Track role, durability, and category growth by season.
Full data
| Season | PTS |
|---|---|
| 21-22 | 15.2 |
| 22-23 | 18.6 |
| 23-24 | 19.7 |
| 24-25 | 24.2 |
| 25-26 | 20.6 |
| 26-27 Projection | 20.1 |
Within-Season Trend
PTS by month across 25-26 (averages). Useful for spotting injury recovery and rookie/second-year ramps. Change the stat with the selector above.
Fantasy playoffs (final ~3 weeks)NBA playoffs (aggregate — not in averages or ranks)
Full data
| Month | PTS |
|---|---|
| Oct 2025 | 22.2 |
| Nov 2025 | 23.1 |
| Dec 2025 | 22.3 |
| Jan 2026 | 16 |
| Feb 2026 | 9.5 |
| Apr 2026 | 17.2 |
| Playoffs (playoffs) | 16.8 |
Fantasy playoffs run the final ~3 weeks of the season (late March into April); shown approximately at month resolution and dependent on your league's settings. ESPN and Yahoo defaults differ by about a week.
Depth Chart
Depth Chart
ORL — all five positions, best player first at each spot.
Season History
Compare season stats and fantasy ranks for draft analysis.
| SeasonNBA season | AgeAge during the season | TeamTeam | GPGames played | GSGames started | MPGMinutes per game | RankOverall fantasy rank (averages) | ValueFantasy ranking value (averages) | PTSPoints per game | REBRebounds per game | ASTAssists per game | STLSteals per game | BLKBlocks per game | 3PMThree-pointers made per game | FG%Field goal percentage | FGAField goal attempts per game | FT%Free throw percentage | FTAFree throw attempts per game | TOTurnovers per game |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26-27 ProjectionModel Zero | 25 | ORL | 52 | 0 | 29.8 | #59 | 4.54 | 20.1 | 5 | 3.5 | 1.1 | 0.3 | 1.3 | 47.4% | 15.5 | 84.9% | 4.9 | 1.7 |
| 25-26 | 24 | ORL | 34 | 0 | 30 | #81 | 3.31 | 20.6 | 5.2 | 3.3 | 0.9 | 0.3 | 1.4 | 48.1% | 14.9 | 82.3% | 5.8 | 1.7 |
| 24-25 | 23 | ORL | 60 | 0 | 33.7 | #32 | 6.33 | 24.2 | 5.7 | 4.7 | 1.3 | 0.4 | 1.7 | 46.3% | 19.4 | 87.1% | 5.2 | 2.3 |
| 23-24 | 22 | ORL | 72 | 0 | 32.5 | #58 | 4.33 | 19.7 | 5.3 | 3.7 | 1.1 | 0.4 | 1.3 | 48.2% | 15.2 | 85.0% | 4.4 | 1.9 |
| 22-23 | 21 | ORL | 80 | 0 | 32.6 | #100 | 2.67 | 18.6 | 4.1 | 3.5 | 1 | 0.2 | 1.6 | 48.5% | 14 | 84.2% | 4 | 2.1 |
| 21-22 | 20 | ORL | 79 | 0 | 30.7 | #94 | 2.67 | 15.2 | 4.5 | 2.9 | 0.9 | 0.4 | 1.2 | 46.8% | 12.3 | 86.3% | 2.8 | 1.5 |